HIRA to regulate high-priced drugs

Published: 2003-04-24 06:59:00

Updated: 2003-04-24 06:59:00

The Health Insurance Review Agency (HIRA) said at a meeting with parliamentary committee of health and welfare on April 21 that the agency will push to discourage the use of high-priced prescription drugs in the medical institutions and reduce the prescription number of branded items this year, i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK